178 related articles for article (PubMed ID: 6690009)
21. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.
Barbet J; Campion L; Kraeber-Bodéré F; Chatal JF;
J Clin Endocrinol Metab; 2005 Nov; 90(11):6077-84. PubMed ID: 16091497
[TBL] [Abstract][Full Text] [Related]
22. Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma.
Bockhorn M; Frilling A; Rewerk S; Liedke M; Dirsch O; Schmid KW; Broelsch CE
Thyroid; 2004 Jun; 14(6):468-70. PubMed ID: 15242577
[TBL] [Abstract][Full Text] [Related]
23. Thyroid venous catheterization in the early diagnosis of familial medullary thyroid carcinoma.
Wells SA; Baylin SB; Johnsrude IS; Harrington DP; Mendelsohn G; Ontjes DJ; Cooper CW
Ann Surg; 1982 Nov; 196(5):505-11. PubMed ID: 7125737
[TBL] [Abstract][Full Text] [Related]
24. Identification of occult metastases of medullary thyroid carcinoma by pentagastrin-stimulated intravenous calcitonin sampling followed by targeted surgery.
Schott M; Willenberg HS; Sagert C; Nguyen TB; Schinner S; Cohnen M; Cupisti K; Eisenberger CF; Knoefel WT; Scherbaum WA
Clin Endocrinol (Oxf); 2007 Mar; 66(3):405-9. PubMed ID: 17302876
[TBL] [Abstract][Full Text] [Related]
25. Calcitonin and carcino-embryonic antigen in the follow-up of patients with medullary carcinoma of the thyroid.
Palmer BV; Harmer CL; Shaw HJ
Br J Surg; 1984 Feb; 71(2):101-4. PubMed ID: 6692098
[TBL] [Abstract][Full Text] [Related]
26. Prognostic variables and calcitonin in medullary thyroid cancer.
Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
[TBL] [Abstract][Full Text] [Related]
27. [Plasma tumor markers (calcitonin and carcinoembryonic antigen) in medullary thyroid cancers].
Argémi B; Vagneur JP; Conforto C; Even F; Rollat MC; Simonin R
Bull Cancer; 1984; 71(2):133-9. PubMed ID: 6733293
[TBL] [Abstract][Full Text] [Related]
28. Serum tissue polypeptide antigen (TPA) in thyroid cancer.
Martino E; Bambini G; Aghini-Lombardi F; Motz E; Pacini F; Lari R; Baschieri L; Pinchera A
J Endocrinol Invest; 1984 Jun; 7(3):249-52. PubMed ID: 6547969
[TBL] [Abstract][Full Text] [Related]
29. Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma.
Tisell LE; Hansson G; Jansson S; Salander H
Surgery; 1986 Jan; 99(1):60-6. PubMed ID: 3942001
[TBL] [Abstract][Full Text] [Related]
30. Surgical treatment of postoperative, incidentally diagnosed small sporadic C-cell carcinomas of the thyroid.
Cupisti K; Simon D; Wolf A; Gerharz CD; Goretzki PE; Dotzenrath C; Witte J; Röher HD
Langenbecks Arch Surg; 2000 Dec; 385(8):526-30. PubMed ID: 11201009
[TBL] [Abstract][Full Text] [Related]
31. 111In-pentetreotide scintigraphy in the post-thyroidectomy follow-up of patients with medullary thyroid carcinoma.
Celentano L; Sullo P; Klain M; Lupoli G; Cascone E; Salvatore M
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):131-3. PubMed ID: 9002771
[TBL] [Abstract][Full Text] [Related]
32. Positron emission tomography (18FDG-PET) in the detection of medullary thyroid carcinoma metastases.
Mucha SA; Kunert-Radek J; Pomorski L
Endokrynol Pol; 2006; 57(4):452-5. PubMed ID: 17006852
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen.
Woliński K; Kaznowski J; Klimowicz A; Maciejewski A; Łapińska-Cwojdzińska D; Gurgul E; Car AD; Fichna M; Gut P; Gryczyńska M; Ruchała M
Endokrynol Pol; 2017; 68(4):434-437. PubMed ID: 28585679
[TBL] [Abstract][Full Text] [Related]
34. Role of serum carcinoembryonic antigen in preoperative diagnosis of cancer in patients with thyroid nodules.
Madeddu G; Langer M; Dettori G; Costanza C
Cancer; 1980 May; 45(10):2607-10. PubMed ID: 7378994
[TBL] [Abstract][Full Text] [Related]
35. Carcinoembronic antigen and endocrine response in a patient with Sipple's syndrome following surgery.
Nakada T; Shigematsu H; Nagayama T; Miyauchi T; Yoshida Y; Sakiyama S; Katayama T; Shimada F
Endocrinol Jpn; 1981 Oct; 28(5):551-62. PubMed ID: 6284492
[TBL] [Abstract][Full Text] [Related]
36. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
[TBL] [Abstract][Full Text] [Related]
37. Somatostatin analogs in the treatment of medullary thyroid carcinoma.
Díez JJ; Iglesias P
J Endocrinol Invest; 2002 Oct; 25(9):773-8. PubMed ID: 12398235
[TBL] [Abstract][Full Text] [Related]
38. Surgical strategy for the treatment of medullary thyroid carcinoma.
Fleming JB; Lee JE; Bouvet M; Schultz PN; Sherman SI; Sellin RV; Friend KE; Burgess MA; Cote GJ; Gagel RF; Evans DB
Ann Surg; 1999 Nov; 230(5):697-707. PubMed ID: 10561095
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of early postoperative calcitonin level in medullary thyroid carcinoma.
Girelli ME; Dotto S; Nacamulli D; Piccolo M; De Vido D; Russo T; Bernante P; Pelizzo MR; Busnardo B
Tumori; 1994 Apr; 80(2):113-7. PubMed ID: 8016900
[TBL] [Abstract][Full Text] [Related]
40. Early liver metastases in patients with medullary carcinoma of the thyroid gland.
Gautvik KM; Talle K; Hager B; Jørgensen OG; Aas M
Cancer; 1989 Jan; 63(1):175-80. PubMed ID: 2910415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
